ProtoKinetix, Incorporated ( www.protokinetix.com ) (the “Company” or “ProtoKinetix”) (OTCQB: PKTX ), a clinical-stage biomedical company, today announced an update to the Press Release of January 24, 2020. We have now completed the...
EDMONTON, March 24, 2020 /PRNewswire/ – OncoQuest Inc. (“OncoQuest” or the “Company”), a privately held, cancer immunotherapy company today announced the publication of two reports relating to the recently completed Phase 2 trial...
ANN ARBOR, Mich., March 23, 2020 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced that two pooled analyses from four Phase 3 clinical trials of NEXLETOL and results from the Phase 2 (1002-058) study of NEXLIZET will be presented at the American College...
Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that following a successful clinical evaluation of its Logix Smart™ COVID-19 Test, the Company will begin...
RALEIGH, N.C., March 20, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences announced today the commercial availability of the COVID-19 Monitoring Program, a mobile app-driven, tiered initiative that allows employers, payers, providers and health systems to track the...
SOUTH SAN FRANCISCO, Calif., March 23, 2020 /PRNewswire/ — Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of serious fibrotic diseases, today announced that it has...
Email
Text